Table 4.
Characteristics classified by pathological complete response
| Pathological complete response | P-value | ||
|---|---|---|---|
| No (<100%) | Yes (100%) | ||
| n = 24 | n = 7 | ||
| RECIST | |||
| CR | 0(0%) | 7(100%) | P<0.001 |
| PR | 16(66.7%) | 0(0%) | |
| SD | 8(33.3%) | 0(0%) | |
| PD | 0(%) | 0(0%) | |
| Age | |||
| ≥65 | 8(33.3%) | 1(14.3%) | 0.639 |
| <65 | 16(66.7%) | 6(85.7%) | |
| Sex | |||
| Male | 18(75%) | 5(71.4%) | 1 |
| Female | 6(25%) | 2(28.6%) | |
| Smoking status | |||
| Current or former smoker | 14(58.3%) | 2(28.6%) | 0.22 |
| Never smoked | 10(41.7%) | 5(71.4%) | |
| ECOG Physical Score | |||
| 0 | 15(62.5%) | 3(42.9%) | 0.413 |
| 1 | 9(37.5%) | 4(57.1%) | |
| Preoperative nodal stage | |||
| N1 | 17(70.8%) | 4(57.1%) | 0.652 |
| N2 | 7(29.2%) | 3(42.9%) | |
| Downstaging of nodal status in patients with N2 or N1 at baseline | |||
| N2 to N2 or N1 to N1 | 15(62.5%) | 0(0%) | 0.007 |
| N2 to N1/N0 or N1 to N0 | 9(37.5%) | 7(100%) | |
| Stage at presentation | |||
| IIA | 10(41.6%) | 2(28.6%) | 0.757 |
| IIB | 7(29.2%) | 2(28.6%) | |
| IIIA | 7(29.2%) | 3(42.8%) | |
| PD-L1 expression | |||
| >1% | 10(41.6%) | 6(85.8%) | 0.083 |
| ≤1% | 14(58.4%) | 1(14.2%) | |
| TMB (Tumor mutational burden) | |||
| >5.7 | 9(37.5%) | 6(85.8%) | 0.037 |
| ≤5.7 | 15(62.5%) | 1(14.2%) | |